The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The VEGF receptor neuropilin 2 promotes homologous recombination by stimulating YAP/TAZ-mediated Rad51 expression
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 28, Pages 14174-14180
Publisher
Proceedings of the National Academy of Sciences
Online
2019-06-25
DOI
10.1073/pnas.1821194116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival
- (2018) Daniel Grun et al. ONCOGENE
- Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies
- (2018) Sabrina Rizzolio et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
- (2018) Francesca Zanconato et al. NATURE MEDICINE
- VEGF–neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin
- (2018) Ameer L. Elaimy et al. Science Signaling
- Targeting VEGF–neuropilin interactions: a promising antitumor strategy
- (2018) Kewen Peng et al. DRUG DISCOVERY TODAY
- Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
- (2018) Ameer L. Elaimy et al. Science Signaling
- BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
- (2017) Weixing Zhao et al. NATURE
- BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance
- (2017) Alexandra A Duarte et al. NATURE METHODS
- Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication
- (2016) Stephen K. Godin et al. Biochemistry and Cell Biology
- Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
- (2016) Alaa Tarig Alshareeda et al. BREAST CANCER RESEARCH AND TREATMENT
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
- (2016) Yajing Liu et al. CLINICAL CANCER RESEARCH
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer
- (2016) Hira Lal Goel et al. Cell Reports
- Tead and AP1 Coordinate Transcription and Motility
- (2016) Xiangfan Liu et al. Cell Reports
- Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology
- (2015) Samikshan Dutta et al. CANCER RESEARCH
- Rho-Signaling-Directed YAP/TAZ Activity Underlies the Long-Term Survival and Expansion of Human Embryonic Stem Cells
- (2015) Masatoshi Ohgushi et al. Cell Stem Cell
- Aerobic glycolysis tunes YAP/TAZ transcriptional activity
- (2015) E. Enzo et al. EMBO JOURNAL
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- (2015) Fergus J. Couch et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
- (2015) Steven J. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1
- (2015) Chunyan Wang et al. Oncotarget
- Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing
- (2014) Priyanka Sharma et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation of Rad51 promoter
- (2014) Christopher M Hine et al. CELL CYCLE
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- Regulated Splicing of the α6 Integrin Cytoplasmic Domain Determines the Fate of Breast Cancer Stem Cells
- (2014) Hira Lal Goel et al. Cell Reports
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
- (2013) Hira Lal Goel et al. EMBO Molecular Medicine
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Neuropilin-1Stimulates Tumor Growth by Increasing Fibronectin Fibril Assembly in the Tumor Microenvironment
- (2012) Usman Yaqoob et al. CANCER RESEARCH
- RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells
- (2012) Brian Budke et al. NUCLEIC ACIDS RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Homologous recombination in cancer development, treatment and development of drug resistance
- (2010) T. Helleday CARCINOGENESIS
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
- (2010) E. Geretti et al. MOLECULAR CANCER RESEARCH
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
- (2008) Maresa Caunt et al. CANCER CELL
- Use of the Rad51 promoter for targeted anti-cancer therapy
- (2008) C. M. Hine et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started